Breaking News Instant updates and real-time market news.

BEAV

B/E Aerospace

$59.79

0.25 (0.42%)

, COL

Rockwell Collins

$92.96

2.06 (2.27%)

12:48
11/27/16
11/27
12:48
11/27/16
12:48

Arbitrage opportunities arise under Trump administration, Barron's says

President-elect Donald Trump's administration will likely take a softer stance on mergers, Barron's contends in a feature article. The publication names several attractive arbitrage opportunities ahead of Trump's inauguration, including B/E Aerospace (BEAV)-Rockwell Collins (COL), Cabela's (CAB)-Bass Pro Shops, Harman (HAR)-Samsung (SSNLF), NXP Semiconductors (NXPI)-Qualcomm (QCOM), and WhiteWave (WWAV)-Danone (DANOY). Elsewhere in arbitrage land, the pending combination of AT&T (T) and Time Warner (TWX) was criticized by Trump during his campaign, but Barron's argues that a now-President Trump "might feel differently." Bayer's (BAYRY) deal for Monsanto (MON), however, looks riskier and "might be more suited for speculators than investors." Reference Link

BEAV

B/E Aerospace

$59.79

0.25 (0.42%)

COL

Rockwell Collins

$92.96

2.06 (2.27%)

CAB

Cabela's

$62.50

0.32 (0.51%)

HAR

Harman

$109.74

0.24 (0.22%)

SSNLF

Samsung

NXPI

NXP Semiconductors

$99.51

0.18 (0.18%)

QCOM

Qualcomm

$68.29

0.16 (0.23%)

WWAV

WhiteWave

$55.19

0.07 (0.13%)

DANOY

Danone

$12.71

0.315 (2.54%)

T

AT&T

$39.21

0.48 (1.24%)

TWX

Time Warner

$93.20

0.42 (0.45%)

BAYRY

Bayer

$94.14

0.855 (0.92%)

MON

Monsanto

$102.56

0.14 (0.14%)

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

  • 13

    Dec

  • 10

    Jan

  • 27

    Jan

  • 13

    Mar

BEAV B/E Aerospace
$59.79

0.25 (0.42%)

10/25/16
BARD
10/25/16
DOWNGRADE
BARD
Neutral
B/E Aerospace downgraded to Neutral from Outperform at Baird
Baird downgraded B/E Aerospace (BEAV) to Neutral following the pending acquisition by Rockwell Collins (COL) for $62 per share.
10/25/16
WOLF
10/25/16
DOWNGRADE
WOLF
Peer Perform
B/E Aerospace downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research downgraded B/E Aerospace (BEAV) to Neutral following the pending acquisition by Rockwell Collins (COL) for $62 per share.
10/28/16
VERT
10/28/16
INITIATION
VERT
Hold
B/E Aerospace initiated with a Hold at Vertical Research
11/10/16
DBAB
11/10/16
DOWNGRADE
Target $62
DBAB
Hold
B/E Aerospace downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Myles Walton downgraded B/E Aerospace (BEAV) to Hold citing the likelihood of the Rockwell Collins (COL) buyout closing next spring. The analyst keeps a $62 price target for the shares.
COL Rockwell Collins
$92.96

2.06 (2.27%)

11/23/16
WOLF
11/23/16
INITIATION
Target $104
WOLF
Outperform
Rockwell Collins initiated with an Outperform at Wolfe Research
Wolfe Research initiated Rockwell Collins with an Outperform and a $104 price target citing valuation, ramping cash flows, and free cash flow conversions in FY18.
11/23/16
11/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Philips (PHG) initiated with a Buy at Citi. 2. Rockwell Collins (COL) initiated with an Outperform at Wolfe Research. 3. Golar LNG (GLNG) assumed with a Buy at Seaport Global. 4. Cincinnati Bell (CBB) initiated with a Buy at Drexel Hamilton. 5. ZTO Express (ZTO) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/28/16
VERT
10/28/16
INITIATION
VERT
Hold
Rockwell Collins initiated with a Hold at Vertical Research
CAB Cabela's
$62.50

0.32 (0.51%)

10/03/16
FLTL
10/03/16
DOWNGRADE
FLTL
Hold
Cabela's downgraded to Hold from Buy at Feltl
Feltl downgraded Cabela's to Hold following the acquisition by Bass Pro Shops for $65.50 per share.
07/06/16
DADA
07/06/16
NO CHANGE
DADA
Gun sales could continue to be strong through fall, says DA Davidson
Noting that firearm background checks jumped 28.6% year-over-year last month, DA Davidson attributes the surge to the Orlando terrorist attack and subsequent efforts to pass new gun control legislation. The firm thinks that continued pro-gun control rhetoric could create "a tailwind" for gun sales through the fall. DA Davidson says that Sportsman's Warehouse's (SPWH) valuation is attractive after the stock fell over 30% so far this year. It keeps a Buy rating on the shares. The firm keeps a Neutral rating on Cabela's (CAB). Smith & Wesson (SWHC) and Sturm, Ruger (RGR) manufacture guns.
10/04/16
LEHM
10/04/16
DOWNGRADE
Target $64
LEHM
Equal Weight
Cabela's downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Matthew McClintock downgraded Cabela's to Equal Weight saying the takeover offer from Bass Pro Shops fully values the company's assets. The analyst raised his price target for the shares to $64 from $50.
10/03/16
MKMP
10/03/16
DOWNGRADE
MKMP
Neutral
Cabela's downgraded to Neutral from Buy at MKM Partners
MKM Partners downgraded Cabela's to Hold following the acquisition by Bass Pro Shops for $65.50 per share.
HAR Harman
$109.74

0.24 (0.22%)

11/16/16
DBAB
11/16/16
DOWNGRADE
Target $112
DBAB
Hold
Harman downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Rod Lache downgraded Harman International to Hold citing valuation following Samsung's takeout offer. The analyst has a $112 price target for the shares.
11/15/16
LEHM
11/15/16
DOWNGRADE
Target $111
LEHM
Equal Weight
Harman downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Brian Johnson downgraded Harman International to Equal Weight and raised his price target for the shares to $111 from $104 following the acquisition by Samsung. The analyst does not expect a topping bidder from autos, but says other tech firms might emerge.
11/15/16
RAJA
11/15/16
DOWNGRADE
Target $112
RAJA
Outperform
Harman downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Tavis McCourt downgraded Harman to Outperform and raised its price target to $112 from $110 following the acquisition by Samsung. The analyst said financing and regulatory risks of the transaction are very low and sees a small chance of a superior bid.
11/15/16
GSCO
11/15/16
DOWNGRADE
GSCO
Neutral
Harman downgraded to Neutral from Buy at Goldman
Goldman analyst David Tamberrino downgraded Harman to Neutral following the acquisition by Samsung.
SSNLF Samsung

10/26/16
NEED
10/26/16
NO CHANGE
Target $150
NEED
Strong Buy
Needham recommends buying Apple on Pokemon Go, Samsung upside
Following Apple's (AAPL) Q4 results, Needham analyst Laura Martin notes that iPhone revenue rose driven in part by Samsung's (SSNLF) Galaxy Note 7 imploding in September and estimates $10B-$20B of brand value transfers to Apple during the next adoption cycle owing to Samsung's poor handling of the replacement, recall and ultimate discontinuation of the Note 7. Of the company's extra services revenue quarter over quarter, the analyst's channel checks indicate that Niantic and Nintendo's (NTDOY) Pokemon Go represented much of the growth. Martin reiterates a Strong Buy and $150 price target on Apple's shares.
11/01/16
ADAM
11/01/16
NO CHANGE
Target $13
ADAM
Buy
DSP Group long-term thesis remains on track, says Canaccord
Canaccord analyst Matthew Ramsay noted DSP Group (DSPG) reported strong September results driven by record revenue in new product categories. The analyst noted new design wins and said the company is well positioned to yield a return to solid sales growth at higher margins and has the financial position to secure business with large customers. Ramsay reiterated his Buy rating but lowered his price target to $13 from $14 based on the Samsung (SSNLF) Note 7 cancellation.
11/01/16
BMUR
11/01/16
NO CHANGE
Target $25
BMUR
Buy
Integrated Device continues to push through rough patch, says Brean Capital
Brean Capital analyst Mike Burton noted Integrated Device (IDTI) reported relatively in-line Q1 results and gave mixed guidance as the company is being impacted by Samsung's (SSNLF) Note 7 recall. The analyst believes the company is working through its rough patch and executing well on the margin and cost side of its business model. Burton reiterated his Buy rating and raised his price target to $25 from $23 on Integrated Device shares.
10/18/16
UBSW
10/18/16
NO CHANGE
Target $127
UBSW
Buy
Apple near-term outlook improved, says UBS
UBS analyst Steven Milunovich believe Apple's (AAPL) Q4 guidance could have upside due to an extra week in the quarter and checks that show iPhone 7 demand is a bit better than the iPhone 6s. The analyst also noted the Samsung (SSNLF) Note 7 problem remains a wild card, but believes it should help Apple's retention rate. Milunovich said the current Apple share price reflects a gradual erosion of its installed base and the amount people are willing to spend with Apple, which he believes is conservative. Milunovich reiterated his Buy rating and $127 price target on Apple shares.
NXPI NXP Semiconductors
$99.51

0.18 (0.18%)

10/31/16
NOMU
10/31/16
UPGRADE
Target $80
NOMU
Buy
Qualcomm upgraded to Buy from Neutral at Nomura
Nomura analyst Romit Shah upgraded Quallcomm (QCOM) to Buy and raised its price target to $80 from $55 due to earnings accretion from the NXP Semiconductors (NXPI) acquisition. The analyst sees 30% earnings accretion from the deal in 2018 and expects the multiple to expand 1-2x.
11/01/16
PACS
11/01/16
DOWNGRADE
PACS
Sector Weight
NXP Semiconductors downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst John Vinh downgraded NXP Semiconductors (NXPI) to Sector Weight citing the pending takeover by Qualcomm (QCOM). The analyst does not anticipate other competing offers or any regulatory issues to block the deal.
11/02/16
MZHO
11/02/16
DOWNGRADE
MZHO
Neutral
NXP Semiconductors downgraded to Neutral from Buy at Mizuho
Mizuho downgraded NXP Semiconductors (NXPI) to Neutral after the company reached an agreement to be acquired for $110 per share by Qualcomm (QCOM).
10/28/16
10/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Electronic Arts (EA) downgraded to Market Perform from Outperform at Cowen with analyst Doug Creutz saying he believes Titanfall 2 sales are going to be "substantially disappointing" and lowered his unit sales estimate to 6M from 9M. 2. GNC Holdings (GNC) downgraded to Underperform from Neutral at BofA/Merrill and to Underweight from Neutral at Piper Jaffray. 3. McKesson (MCK) downgraded to Hold from Buy at Deutsche Bank, to Neutral from Outperform at Baird, and to Market Perform from Outperform at Leerink. 4. NXP Semiconductors (NXPI) downgraded to Underperform from Outperform at CLSA, to Neutral from Outperform at Baird, to Hold from Buy at SunTrust, to Equal Weight from Overweight at Morgan Stanley, and to Perform from Outperform at Oppenheimer. 5. StoneMor Partners (STON) downgraded to Market Perform from Outperform at Raymond James, to Neutral from Buy at Janney Capital, and to Hold from Buy at Wunderlich. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
QCOM Qualcomm
$68.29

0.16 (0.23%)

11/10/16
11/10/16
DOWNGRADE
Target $65

Equal Weight
Qualcomm downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded Qualcomm (QCOM) to Equal Weight from Overweight. Analyst James Faucette said Qualcomm's valuation adequately reflects incremental smartphone opportunities and NXP Semiconductor (NXPI) contribution and maintained his $65 price target on shares.
11/10/16
11/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comerica (CMA) downgraded to Neutral from Outperform at Baird with analyst David George saying he sees a more balanced risk/reward as the company is already getting significant credit for earnings leverage from its efficiency program. 2. Qualcomm (QCOM) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Qualcomm's valuation adequately reflects incremental smartphone opportunities and NXP Semiconductor (NXPI) contribution. 3. CSX (CSX) downgraded to Market Perform from Outperform at BMO Capital with analyst Fadi Chamoun saying the company will be hurt in the near-term by "an over-supplied trucking market," while its cost savings are expected to decelerate next year and macro economic trends will become less favorable to the company. 4. SolarEdge (SEDG) downgraded to Market Perform from Outperform at JMP Securities, to Market Perform from Outperform at FBR Capital, and to Neutral from Buy at Roth Capital. 5. Capitala Finance (CPTA) downgraded to Perform from Outperform at Oppenheimer and to Neutral from Buy at Ladenburg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/16
MKMP
11/22/16
NO CHANGE
MKMP
Buy
MKM Partners raises NVIDIA, AMD price targets on inflecting semi opportunities
MKM Partners analyst Ian Ing raised his price target for NVIDIA (NVDA) to $106 from $87, saying that thematic attention is heating up as large suppliers are crowding into artificial intelligence as an investment theme with non-GPU solutions. While other suppliers may be able to come up with better performance-for-power in certain use cases, he believes NVIDIA GPUs still have user stickiness with developer incumbency and easy-to-use tools that will be difficult to overcome. The analyst also raised his price target for AMD (AMD) to $10.50 from $8 to reflect improved prospects for the company driven by new product pipeline. Although Ian expects AMD to be a relatively minor player, its shares are helped by continued A.I. headlines and NVIDIA, Intel (INTC), and Qualcomm (QCOM) turning increasingly vocal on the opportunity. He reiterates a Buy rating on NVIDIA and AMD shares.
11/10/16
MSCO
11/10/16
DOWNGRADE
MSCO
Equal Weight
Qualcomm downgraded to Equal Weight from Overweight at Morgan Stanley
WWAV WhiteWave
$55.19

0.07 (0.13%)

10/21/16
SUSQ
10/21/16
DOWNGRADE
SUSQ
Neutral
WhiteWave downgraded to Neutral from Positive at Susquehanna
10/04/16
BERN
10/04/16
NO CHANGE
BERN
Danone deal for WhiteWave unlikely to be challenged, says Bernstein
Bernstein analyst Alexia Howard said the DoJ plan to file a "second request" in its review of Danone's (DANOY) agreement to acquire WhiteWave Foods (WWAV) might delay the closing, but she believes that the transaction is very likely to close at the announced price of $56.25. She argues that the arguments for the existence of antitrust issues are weak and that any issues that may exist are likely small and addressable.
09/09/16
BERN
09/09/16
DOWNGRADE
Target $56
BERN
Market Perform
WhiteWave downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Alexia Howard downgraded WhiteWave Foods to Market Perform with a $56 price target.
08/24/16
ARGS
08/24/16
DOWNGRADE
ARGS
Sell
WhiteWave downgraded to Sell from Buy at Argus
Argus downgraded WhiteWave (WWAV) to Sell based on the company's agreement to be acquired by Danone (DANOY).
DANOY Danone
$12.71

0.315 (2.54%)

07/13/16
JEFF
07/13/16
DOWNGRADE
Target $56
JEFF
Hold
WhiteWave downgraded to Hold from Buy at Jefferies
Jefferies analyst Akshay Jagdale downgraded WhiteWave Foods (WWAV) to Hold saying the chance of a higher, alternative bid to Danone's (DANOY) is "fairly remote." The synergies expected by Danone are unlikely to be topped by alternative bidders, the analyst contends. Jagdale has a $56 price target for WhiteWave shares.
08/10/16
DADA
08/10/16
DOWNGRADE
DADA
Neutral
WhiteWave downgraded to Neutral from Buy at DA Davidson
DA Davidson downgraded WhiteWave (WWAV) based on the company's agreement to be acquired by Danone (DANOY).
09/09/16
DBAB
09/09/16
DOWNGRADE
DBAB
Sell
Danone downgraded to Sell from Hold at Deutsche Bank
T AT&T
$39.21

0.48 (1.24%)

11/02/16
PIVT
11/02/16
UPGRADE
Target $106
PIVT
Buy
Time Warner upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Time Warner (TWX) to Buy with a $106 price target following the company's Q3 results. The analyst sees value in the stock due to the pending buyout by AT&T (T).
11/04/16
DBAB
11/04/16
NO CHANGE
Target $108
DBAB
Buy
Time Warner risk/reward remains attractive, says Deutsche Bank
Deutsche Bank analyst Bryan Kraft believes Time Warner's (TWX) attractive risk/reward "remains in place." The analyst continue to see limited downside if the takeover by AT&T (T) is not approved by regulators. Time Warner trades at only 9% above its pre-deal speculation stock price, Kraft tells investors in a research note, while pointing out that he has a $95 standalone 12-month valuation for the shares. The analyst keeps a Buy rating on the shares with a $108 price target.
11/08/16
11/08/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at Northcoast. 2. AT&T (T) downgraded to Perform from Outperform at Oppenheimer with analyst Timothy Horan saying CenturyLink's (CTL) dividend is "relatively more attractive." 3. Bank of America (BAC) and Citizens Financial (CFG) downgraded to Hold from Buy at Deutsche Bank. 4. OneMain (OMF) downgraded to Market Perform from Outperform at Keefe Bruyette, to Neutral from Buy at Guggenheim, to Underperform from Buy at BofA/Merrill, to Neutral from Buy at Janney Capital, to Market Perform from Outperform at FBR Capital, and to Neutral from Outperform at Wedbush. 5. KeyCorp (KEY) and Goldman Sachs (GS) downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/16
OPCO
11/08/16
DOWNGRADE
OPCO
Perform
AT&T downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Timothy Horan downgraded AT&T (T) to Perform saying CenturyLink's (CTL) dividend is "relatively more attractive." The analyst this morning upgraded CenturyLink to Outperform. Horan also believes AT&T's acquisition of Time Warner (TWX) will face higher regulatory hurtles than CenturyLink's deal for Level 3 (LVLT). He expects the Time Warner deal to take 15 months to complete versus nine months for the Level 3 acquisition.
TWX Time Warner
$93.20

0.42 (0.45%)

11/07/16
11/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Outperform from Neutral at Credit Suisse with analyst Omar Sheikh citing attractive valuation. 2. Waste Management (WM) upgraded to Overweight from Equal Weight at Barclays with analyst Jon Windham saying the recent pullback in shares provides a buying opportunity given the company's "strong" underlying fundamentals. 3. Parker-Hannifin (PH) upgraded to Buy from Hold at Evercore ISI and to Overweight from Equal Weight at Morgan Stanley. 4. Biogen (BIIB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Joshua Schimmer saying the company still has time to "get its act together to maximize the value of its SMA franchise, and stop being M&A disciplined/pipeline-undisciplined." 5. Cummins (CMI) upgraded to Buy from Hold at Evercore ISI with analyst David Raso citing lowered expectations, valuation, and accelerating inflation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MOFT
11/17/16
UPGRADE
MOFT
Buy
Time Warner upgraded to Buy from Sell at MoffettNathanson
11/17/16
11/17/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Microsoft (MSFT) upgraded to Buy from Neutral at Goldman with analyst Heather Bellini saying Azure is the number two market share vendor in the cloud space, and has grown 100% or more year-over-year eight of the last 10 quarters. 2. Time Warner (TWX) upgraded to Buy from Sell at MoffettNathanson. 3. First Solar (FSLR) upgraded at JMP Securities with analyst Joseph Osha citing valuation. 4. KBR (KBR) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Anna Kaminskaya saying she expects structurally higher defense spending to drive a re-rating in KBR and sees less risk of cost overruns in the E&C business given lower reliance on fixed priced contracts and diversification into smaller sized service projects. 5. Liberty Interactive (QVCA) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Heather Balsky saying she has increased confidence in a return to positive US sales growth and expects multiple expansion as sales improve. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BAYRY Bayer
$94.14

0.855 (0.92%)

09/15/16
PIPR
09/15/16
NO CHANGE
Target $128
PIPR
Overweight
Piper has confidence in closing of Monsanto, Bayer merger
Piper Jaffray analyst Brett Wong raised his price target for Monsanto (MON) to $128 citing the takeover price paid by Bayer (BAYRY). The analyst views the offer price as lower than expected but has confidence regulatory approval will be granted since there is a minimal crossover between the two companies. He reiterates an Overweight rating on Monsanto.
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded on acquisition at Bernstein
As noted earlier, Bernstein upgraded Monsanto (MON) to Market Perform from Underperform. Analyst Jonas Oxgaard upgraded the stock after Bayer (BAYRY) agreed to buy Monsanto. However, he warned that "it's too early to tell" whether regulators will approve the deal, and he says that the risk is "skewed to the downside in the near-term." He recommends that investors avoid the stock for 6-9 months. Target to $105 from $90.
09/21/16
JPMS
09/21/16
UPGRADE
Target $128
JPMS
Overweight
Monsanto upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Monsanto (MON) to Overweight saying the risk in the shares is "less than what the market assumes." The analyst believes downside risk should the takeover by Bayer (BAYRY) fail is around $100 per share. He notes that Monsanto shareholders would receive $128 per share should the acquisition close. Zekauskas raised his price target for Monsanto to $128 from $100.
09/15/16
BERN
09/15/16
NO CHANGE
BERN
Bayer acquisition negative, says Bernstein
After Bayer (BAYRY) agreed to buy Monsanto (MON), Bernstein analyst Jonas Oxgaard says he "continues to have a bearish view" of Monsanto's business, and he thinks that Monsanto's price exceeded the company's true value by about 60%. The analyst adds that the genetically modified products that Monsanto is developing "are not expected to command outsized premiums," while genetically modified seeds have nearly fully penetrated most of the Americas. He keeps an Underperform rating on Monsanto and an Outperform rating on Bayer.
MON Monsanto
$102.56

0.14 (0.14%)

09/27/16
GSCO
09/27/16
UPGRADE
GSCO
Neutral
Monsanto upgraded to Neutral from Sell at Goldman
11/18/16
OTRG
11/18/16
UPGRADE
OTRG
Mixed
Monsanto upgraded to Mixed from Negative at OTR Global
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded to Market Perform from Underperform at Bernstein

TODAY'S FREE FLY STORIES

DE

Deere

$101.50

-1.2 (-1.17%)

13:12
12/04/16
12/04
13:12
12/04/16
13:12
Periodicals
Deere could keep climbing, Barron's says »

Deere stock recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$9.81

0.28 (2.94%)

, GME

GameStop

$24.27

-0.37 (-1.50%)

12:57
12/04/16
12/04
12:57
12/04/16
12:57
Periodicals
Corporate tax cut can't save all retailers, Barron's says »

Though President-elect…

JCP

J.C. Penney

$9.81

0.28 (2.94%)

GME

GameStop

$24.27

-0.37 (-1.50%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

TJX

TJX

$77.10

-0.57 (-0.73%)

FL

Foot Locker

$74.23

0.55 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

ELY

Callaway Golf

$11.68

-0.3 (-2.50%)

12:40
12/04/16
12/04
12:40
12/04/16
12:40
Periodicals
Callaway Golf investors should take profits, Barron's says »

It "looks like a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVC

Entravision

12:36
12/04/16
12/04
12:36
12/04/16
12:36
Periodicals
Entravision shares could reach $9, Barron's says »

Hispanic-focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GOOG

Alphabet

$750.50

2.58 (0.34%)

, GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

12:26
12/04/16
12/04
12:26
12/04/16
12:26
Periodicals
Barron's picks top ten stocks for 2017 »

Selecting its ten…

GOOG

Alphabet

$750.50

2.58 (0.34%)

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

AAPL

Apple

$109.90

0.41 (0.37%)

C

Citi

$56.02

-1.25 (-2.18%)

DAL

Delta Air Lines

$48.31

0.54 (1.13%)

DTEGY

Deutsche Telekom

$15.65

0.14 (0.90%)

MRK

Merck

$61.13

0.37 (0.61%)

NVS

Novartis

$68.17

0.42 (0.62%)

TOL

Toll Brothers

$29.32

0.18 (0.62%)

UL

Unilever; also tag UN

$39.67

0.5 (1.28%)

UN

Unilever; also tag UL

$39.47

0.35 (0.89%)

DIS

Disney

$98.50

-0.44 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 15

    Jan

  • 26

    Jan

  • 08

    Mar

  • 13

    Mar

TWTR

Twitter

$17.93

-0.1 (-0.55%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Periodicals
Early Twitter investor Sacca would 'love' to see the company sold, CNBC reports »

One of the earliest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.